flow trial semaglutide chronic kidney disease results 2024 clinical (funded by Novo Nordisk): showed 24% reduction in the risk of disease-related events in people with type 2 diabetes and kidney compared to placebo. Investigators Diabetes Distilled: Keeping kidneys FLOWing

The most common side effects of this medicine ae reduction of bone density and upset stomach

Patients should also carry alcohol swabs, sharps containers, and any necessary supplies

Resveratrol protects against nonalcoholic fatty liver disease by improving lipid metabolism and redox homeostasis via the PPAR pathway

The overall population-level efficacy (13.6% when accounting for all randomized participants regardless of discontinuation) is somewhat lower, partly reflecting the stricter administration requirements of the oral formulation

These are genuinely striking numbers

Hence, estrogen deficiency causes leaky gut, where the microbial products can translocate systemically, provoking the innate immune system via activation of NLRP3 inflammasome, underlying similar events (245)